Project Grant R01GM155497
- This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research aimed at understanding how protein phosphatases in bacteria and humans are regulated and directed to specific substrates. The $393,149 grant, awarded on June 1, 2025, will fund research conducted by Brandeis University over a 5-year period, with a planned completion date of March 31, 2030. The...
- This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $408,521 over 3 years to support research at the University of Portland on the function and regulation of the C. elegans HASPIN histone kinase homolog, HASP-1. The research aims to: 1) Determine the relative contribution of the HASPIN and BUB1 pathways to chromosomal passenger complex (CPC) recruitment in different...
- This Project Grant award of $390,000.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to elucidate the molecular mechanisms that regulate basal autophagy in distinct cell types. The central hypothesis is that the PROPPIN (B-PROPELLERS THAT BIND PHOSPHOINOSITIDES) family members WIPI1-WIPI4 differentially regulate basal autophagy at discrete developmental stages across different...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $528,129 to the University of Connecticut Health Center (UCHC) to structurally and functionally characterize critical ubiquitinating and de-ubiquitinating enzymes implicated in human diseases. The overarching goal is to develop a detailed understanding of how the ubiquitin-proteasome pathway (UPP) components recognize...
- This federal Project Grant award of $946,895 from the National Science Foundation's (NSF) Division of Molecular and Cellular Biosciences (CFDA 47.074 Biological Sciences) will fund research to advance the understanding of protein phosphorylation and its role in coordinating cell division. The project aims to identify new enzymes that carry out phosphorylation and the substrate proteins they modify to ensure proper cell division. Researchers will employ computational, biochemical, proteomic,...
- This federal Project Grant award of $125,000.00 from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) to New York University (NYU) aims to elucidate the role of the cyclin D1-CDK4/6 complex in regulating protein homeostasis. The research project will employ advanced structural techniques to understand how cyclin D-dependent phosphorylation modulates the interface between key endoplasmic reticulum-associated degradation (ERAD) effectors....
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate the structural and functional effects of phosphorylation on the intrinsically disordered C-terminal region of the retinoblastoma (RB) tumor suppressor protein. The $211,988 award to The Washington University in St. Louis will leverage computational and experimental approaches, including all-atom...
- This $438,342 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to study the fundamental mechanisms by which ubiquitin ligases recognize and ubiquitinate substrates within protein complexes. The research focuses on understanding the role of the anaphase-promoting complex (APC) in regulating the composition of neuronal...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $561,276 in funding to conduct research on targeting the unfolded protein response (UPR) pathway to induce cell death in multiple myeloma. The research will focus on the UPR master regulator BIP as a potential therapeutic target, and is part of a 5-year mentored career development plan for the principal investigator to become an independent physician-scientist in hematology/oncology. The...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $202,274 to develop an easy-to-use computer program for predicting the structure and degrading efficiency of proteolysis targeting chimeras (PROTACs). PROTACs are heterobifunctional molecules that induce the degradation of target proteins by recruiting them to E3 ubiquitin ligases. The awarded project aims to implement a...
PP2A/B55ALPHA SUBSTRATE SPECIFICITY AND FUNCTION IN CELL CYCLE PROGRESSION - THE GOAL OF THIS PROPOSAL IS TO FULLY DELINEATE THE MOLECULAR MECHANISMS BY WHICH THE PROMINENT SERINE/THREONINE PROTEIN PHOSPHATASE 2 (PP2A) HOLOENZYME, SPECIFICALLY PP2A/B55A, RECOGNIZES ITS SUBSTRATES THROUGH A NEW HELICAL MOTIF AND TO USE THIS INFORMATION TO IDENTIFY DIRECT PP2A/B55A SUBSTRATES WITH FUNCTIONS IN MITOGENIC SIGNALING AND EARLY CELL CYCLE PROGRESSION. PROTEIN PHOSPHORYLATION IS AN ESSENTIAL REGULATORY MECHANISM IN CELL SIGNALING AND THE REGULATION OF THE CELL CYCLE AND IT IS ALTERED IN CANCER, ALZHEIMER, AND OTHER DISEASES. A LARGE FRACTION OF DEPHOSPHORYLATION IS MEDIATED BY DISTINCT PP2A TRIMERIC HOLOENZYMES. THESE CONSIST OF A SCAFFOLD PROTEIN THAT CONNECTS THE CATALYTIC SUBUNIT TO THE VARIABLE REGULATORY SUBUNIT, WHICH MEDIATES SUBSTRATE SPECIFICITY. THE MOST ABUNDANT HOLOENZYME IS PP2A/B55A. ITS ACTIVITY HAS BEEN IMPLICATED IN MITOGENIC SIGNALING AND EARLY CELL CYCLE PROGRESSION, BUT DETAILS REMAIN UNCLEAR. INITIALLY, IT WAS BELIEVED THAT PP2A/B55A RECRUITED SUBSTRATES THROUGH CHARGE-CHARGE INTERACTIONS BETWEEN THE SURFACE OF B55A AND SUBSTRATES. HOWEVER, OUR GROUNDBREAKING DISCOVERIES CHALLENGED THIS NOTION. WE IDENTIFIED A CONSERVED AMINO ACID MOTIF IN VARIOUS PROTEINS, INCLUDING THE P107 SUBSTRATE AND THE FAM122A INHIBITOR, THAT FOLDS AS AN A-HELIX. THIS HELICAL MOTIF IS ESSENTIAL FOR P107 DEPHOSPHORYLATION AND FOR FAM122A BINDING VIA SIMILAR INTERACTIONS WITH RESIDUES IN A GROOVE ON THE TOP OF B55A. THIS MECHANISM IS DISTINCT FROM THAT USED BY OTHER SER/THR PHOSPHATASES THAT BIND SHORT LINEAR MOTIFS IN INTRINSICALLY DISORDERED PROTEIN REGIONS. GAP: DESPITE THIS ADVANCE, WE REMAIN UNABLE TO IDENTIFY OTHER PP2A/B55A SUBSTRATES USING THIS SHORT HELICAL SEQUENCE. THIS IS DUE TO THE LACK OF A COMPREHENSIVE ASSESSMENT OF AMINO ACID VARIABILITY WITHIN THE HELICAL MOTIF SEQUENCE AND INCOMPLETE DETAIL OF THE MOTIF'S STRUCTURAL PLASTICITY. AS A RESULT, IT REMAINS EXTREMELY DIFFICULT TO IDENTIFY NEW SUBSTRATES, TO DISTINGUISH CORRECTLY VS INCORRECTLY ASSIGNED SUBSTRATES, AND TO DEMONSTRATE THE VERACITY OF CORRECTLY ASSIGNED SUBSTRATES. WE HYPOTHESIZE THAT A HELICAL REGION WITH A DEFINED LENGTH AND A VARIABLE CONSERVED AMINO ACID SEQUENCE IN PP2A/B55A SUBSTRATES MEDIATES BINDING TO THE TOP GROOVE OF B55A VIA SPECIFIC ELECTROSTATIC AND HYDROPHOBIC INTERACTIONS. THIS IS A PRIMARY MECHANISM FOR SUBSTRATE RECOGNITION THAT MODULATES SIGNALING THROUGH THE CELL CYCLE. THESE WILL BE TESTED WITH TWO AIMS: (1) TO DEFINE PP2A/B55A SUBSTRATE SPECIFICITY VIA A SHORT HELICAL MOTIF WITH DEFINED SEQUENCES. (2) TO DISSECT THE PP2A/B55A SUBSTRATE INTERPLAY IN MITOGENIC SIGNALING LINKED TO THE CELL CYCLE RESTRICTION POINT (RP). DEIA AIMS: DIVERSITY AMONG TEMPLE UNIVERSITY UNDERGRADUATES IS EXCELLENT, BUT THE TRANSITION OF UNDERREPRESENTED MINORITY (URM) STUDENTS TO BIOMEDICAL SCIENCE RESEARCH CAREERS OR GRADUATE SCHOOLS IS STILL SEVERELY LIMITED. OUR GOAL IS TO IMPLEMENT A PROGRAM WE HAVE BEEN PILOTING THAT IS GEARED TOWARD ELIMINATING BARRIERS TO JOINING THE SCIENTIFIC RESEARCH WORKFORCE FACED BY URM UNDERGRADUATES AT TEMPLE AND NATIONWIDE. THE PROGRAM WILL RECRUIT 15 STUDENTS WHO WILL WORK IN MENTORS' LABS ON A SPECIFIC PROJECT AND RECEIVE PROGRAMMATIC TRAINING TO PREPARE THEM FOR ADMISSION AND SUCCESS IN BIOMEDICAL RESEARCH PHD PROGRAMS. AIM 1 IS TO DEVELOP RESEARCH SKILLS AND KNOWLEDGE AND AIM 2 IS TO DEVELOP CAREER SKILLS BY PROVIDING INSTRUCTION IN FELLOWSHIP WRITING, GRADUATE SCHOOL APPLICATION, ORAL AND WRITING SCIENTIFIC COMMUNICATION, AND SCIENTIFIC NETWORKING. SUCCESSFUL COMPLETION OF THE SCIENTIFIC AIMS WILL FACILITATE IDENTIFICATION OF PP2A/B55A SUBSTRATES AND THEIR VALIDATION IN MULTIPLE PATHWAYS AND CELLULAR PROCESSES OFTEN DEREGULATED IN DISEASE PROVIDING NOVEL TARGETS FOR THERAPEUTIC INTERVENTION. THE DEIA TRAINING PROGRAM WILL GUIDE URM STUDENTS TO PROFESSIONAL RESEARCH CAREERS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 6/5/25 | ||
| Not listed | $662.0k | 7/19/24 | ||
| Not listed | $662.0k | 7/19/24 |